GlassScriptPhysician profile
Amanda Albrecht
NPI 1376251561
$515.32
in general payments reported to CMS, 2019-2025
10 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $49.18 · 2023: $161 · 2024: $113 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $96.04 | 2025 | Dupixent |
| Glaxosmithkline, LLC. | $76.76 | 2023-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Pharming Healthcare, INC. | $75.27 | 2022-2024 | Ruconest |
| Astrazeneca Pharmaceuticals LP | $74.72 | 2024-2025 | Airsupra, Tezspire |
| Genzyme Corporation | $66.95 | 2024-2025 | |
| Tersera Therapeutics LLC | $36.46 | 2023 | Quzyttir |
| Genentech USA, INC. | $25.62 | 2023 | Xolair |
| Leo Pharma INC. | $25.04 | 2022 | |
| Kaleo, INC. | $20.60 | 2023 | Auvi-Q |
| Phadia US INC. | $17.86 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Albrecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.